Johns Hopkins Center for Image-Guided Animal Therapy (CIGAT)

Specialty hospital / research center

3 current cancer treatment or research opportunities

About Johns Hopkins CIGAT

Johns Hopkins CIGAT treats animals inside a major human academic medical center. Its veterinarians and radiologists adapt MRI, CT, focused ultrasound and other image-guided procedures so tumors can be targeted through small or no incisions.

Johns Hopkins CIGAT →

Who the current listings are forDogs
Cancer types currently listedGlioma, Mammary Carcinoma, Osteosarcoma
Where visits take placeJohns Hopkins CIGAT, 600 N Wolfe St, Park 311, Baltimore, MD 21287

Current options at Johns Hopkins Center for Image-Guided Animal Therapy (CIGAT)

Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.

Cryotherapy or intratumoral immunotherapy before amputation for canine osteosarcoma

Johns Hopkins Center for Image-Guided Animal Therapy (CIGAT) · USA

Open and recruiting — listed on the current Johns Hopkins CIGAT clinical-trials page

What is being offered: Treatment trial for histopathologically confirmed canine osteosarcoma. Eligible dogs receive PET-CT and either cryotherapy or two doses of tumor-injected immunotherapy before required amputation at about two weeks, followed by chemotherapy. Johns Hopkins lists no prior osteosarcoma treatment or chemotherapy for other cancers and requires the dog to be systemically healthy apart from osteosarcoma.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Planned amputation and chemo

May not qualify if: Prior chemo; Prior osteosarcoma treatment

Costs / coverage: 🟡 Partially funded. Study covers PET-CT/CT imaging, cryotherapy or intratumoral immunotherapy, study-related medications and follow-up imaging/blood tests; required amputation and chemotherapy are owner-paid.

Contact: Johns Hopkins CIGAT — 410-502-7325; contact through the official clinical-trials page

Location

  • Johns Hopkins CIGAT, 600 N Wolfe St, Park 311, Baltimore, MD 21287

Official study / enrollment information →

Radiation therapy plus temozolomide for canine brain tumors

Johns Hopkins Center for Image-Guided Animal Therapy (CIGAT) · USA

Open and enrolling — current Johns Hopkins CIGAT clinical-trials page

What is being offered: Treatment study for dogs with a suspected glioma/intra-axial brain tumor greater than 1 cm on MRI and restricted to one side of the brain. Protocol uses five consecutive workdays of radiation therapy with concurrent oral temozolomide. Previous or current oncologic treatment of the brain tumor is exclusionary; investigator prescreening is required.

Who may qualify: Active tumor required; Min age years: 1; Min weight kg: 10; Brain tumor present; Planned radiation; Planned chemo

May not qualify if: Prior local radiation; Prior chemo

Costs / coverage: 🟢 Fully funded protocol treatment. Radiation therapy and chemotherapy are fully funded, and study-related side-effect medications, follow-up MRI and blood tests are covered; treatment after progression is not covered.

Contact: Johns Hopkins CIGAT — 410-502-7325; contact through the official clinical-trials page

Location

  • Johns Hopkins CIGAT, 600 N Wolfe St, Park 311, Baltimore, MD 21287

Official study / enrollment information →

Kubanda veterinary cryotherapy for canine mammary cancer

Johns Hopkins Center for Image-Guided Animal Therapy (CIGAT) / Kubanda Cryotherapy · USA

Now recruiting — Phase IB trial listed on the current Johns Hopkins CIGAT clinical-trials page

What is being offered: Current institution master states recruitment for Phase IB Kubanda mammary cryotherapy. Individual official flyer requires histopathologic mammary cancer, no prior treatment of the lump or chemotherapy for other cancers, and systemic fitness. Cryotherapy is followed a few weeks later by surgical mass removal. Other investigational treatment, concurrent study enrollment and life-threatening medical/immunosuppressive illnesses exclude entry. Detailed team screening remains required.

Who may qualify: Active tumor required; Confirmed cancer diagnosis required

May not qualify if: Prior chemo

Costs / coverage: 🟡 Partially funded. Owners pay for diagnosis and staging; the primary study flyer states that cryotherapy and subsequent mass removal are fully funded, with follow-up assessments at no owner cost. Unrelated care and travel coverage are not stated.

Contact: Kubanda Cryotherapy / Johns Hopkins CIGAT — contact through the official clinical-trials page

Location

  • Johns Hopkins CIGAT, 600 N Wolfe St, Park 311, Baltimore, MD 21287

Official study / enrollment information →

Before you contact the center

A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.

Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.

Check all options for your pet →

Free to use. No registration or paid report.